| Diverse applications of nanomedicine B Pelaz, C Alexiou, RA Alvarez-Puebla, F Alves, AM Andrews, S Ashraf, ... ACS nano 11 (3), 2313-2381, 2017 | 1497 | 2017 |
| Locoregional cancer treatment with magnetic drug targeting C Alexiou, W Arnold, RJ Klein, FG Parak, P Hulin, C Bergemann, ... Cancer research 60 (23), 6641-6648, 2000 | 1401 | 2000 |
| Clinical applications of magnetic drug targeting AS Lübbe, C Alexiou, C Bergemann Journal of Surgical Research 95 (2), 200-206, 2001 | 1317 | 2001 |
| Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts C Alexiou, RJ Kau, H Dietzfelbinger, M Kremer, JC Spieß, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1999 | 891 | 1999 |
| Magnetic nanoparticle-based drug delivery for cancer therapy R Tietze, J Zaloga, H Unterweger, S Lyer, RP Friedrich, C Janko, M Pöttler, ... Biochemical and biophysical research communications 468 (3), 463-470, 2015 | 538 | 2015 |
| Targeting cancer cells: magnetic nanoparticles as drug carriers C Alexiou, RJ Schmid, R Jurgons, M Kremer, G Wanner, C Bergemann, ... European biophysics journal 35 (5), 446-450, 2006 | 538 | 2006 |
| Drug loaded magnetic nanoparticles for cancer therapy R Jurgons, C Seliger, A Hilpert, L Trahms, S Odenbach, C Alexiou Journal of Physics: Condensed Matter 18 (38), S2893, 2006 | 422 | 2006 |
| Magnetic drug targeting—biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment C Alexiou, R Jurgons, RJ Schmid, C Bergemann, J Henke, W Erhard, ... Journal of drug targeting 11 (3), 139-149, 2003 | 399 | 2003 |
| Magnetic drug targeting: biodistribution and dependency on magnetic field strength C Alexiou, A Schmidt, R Klein, P Hulin, C Bergemann, W Arnold Journal of Magnetism and Magnetic Materials 252, 363-366, 2002 | 320 | 2002 |
| Efficient drug-delivery using magnetic nanoparticles—biodistribution and therapeutic effects in tumour bearing rabbits R Tietze, S Lyer, S Dürr, T Struffert, T Engelhorn, M Schwarz, E Eckert, ... Nanomedicine: Nanotechnology, Biology and Medicine 9 (7), 961-971, 2013 | 304 | 2013 |
| In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles C Alexiou, R Jurgons, R Schmid, A Hilpert, C Bergemann, F Parak, H Iro Journal of Magnetism and Magnetic Materials 293 (1), 389-393, 2005 | 269 | 2005 |
| Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting C Alexiou, W Arnold, P Hulin, RJ Klein, H Renz, FG Parak, C Bergemann, ... Journal of Magnetism and Magnetic Materials 225 (1-2), 187-193, 2001 | 225 | 2001 |
| Sudden sensorineural hearing loss: does application of glucocorticoids make sense? C Alexiou, W Arnold, C Fauser, B Schratzenstaller, B Gloddek, ... Archives of otolaryngology–head & neck surgery 127 (3), 253-258, 2001 | 201 | 2001 |
| A high field gradient magnet for magnetic drug targeting C Alexiou, D Diehl, P Henninger, H Iro, R Rockelein, W Schmidt, H Weber IEEE Transactions on applied superconductivity 16 (2), 1527-1530, 2006 | 194 | 2006 |
| Medical applications of magnetic nanoparticles C Alexiou, R Jurgons, C Seliger, H Iro Journal of nanoscience and nanotechnology 6 (9-10), 2762-2768, 2006 | 188 | 2006 |
| Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: Evaluation of size-dependent imaging properties, storage stability and safety H Unterweger, L Dézsi, J Matuszak, C Janko, M Poettler, J Jordan, ... International journal of nanomedicine, 1899-1915, 2018 | 180 | 2018 |
| Cancer therapy with drug loaded magnetic nanoparticles—magnetic drug targeting C Alexiou, R Tietze, E Schreiber, R Jurgons, H Richter, L Trahms, H Rahn, ... Journal of Magnetism and Magnetic Materials 323 (10), 1404-1407, 2011 | 177 | 2011 |
| Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis M Kremer, G Ott, M Nathrath, K Specht, K Stecker, C Alexiou, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2005 | 176 | 2005 |
| Lysosome‐targeting amplifiers of reactive oxygen species as anticancer prodrugs S Daum, MSV Reshetnikov, M Sisa, T Dumych, MD Lootsik, R Bilyy, E Bila, ... Angewandte Chemie International Edition 56 (49), 15545-15549, 2017 | 173 | 2017 |
| Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment GF Heidkamp, J Sander, CHK Lehmann, L Heger, N Eissing, A Baranska, ... Science immunology 1 (6), eaai7677, 2016 | 164 | 2016 |
